
Dimension is a venture capital firm focused on partnering with founders at the intersection of technology and life sciences to transform the trajectory of life on earth. The firm invests across biotech platforms, software, infrastructure, lab tools and instruments, clinical development, manufacturing and commercialization, and machine learning and artificial intelligence. Dimension differentiates itself by being deeply fluent in both life sciences and technology, supporting entrepreneurs building next-generation tech and bio businesses. The firm operates with a founder-centric partnership model, investing across stages globally, and emphasizes long-term value creation through platform companies. Its portfolio includes companies innovating in regenerative medicines, AI-driven drug toxicity prediction, and drug discovery simulation models. Dimension is positioned as a company builder and scientific partner, not just a capital allocator, aiming to catalyze the convergence of compute and biology at scale.

Dimension is a venture capital firm focused on partnering with founders at the intersection of technology and life sciences to transform the trajectory of life on earth. The firm invests across biotech platforms, software, infrastructure, lab tools and instruments, clinical development, manufacturing and commercialization, and machine learning and artificial intelligence. Dimension differentiates itself by being deeply fluent in both life sciences and technology, supporting entrepreneurs building next-generation tech and bio businesses. The firm operates with a founder-centric partnership model, investing across stages globally, and emphasizes long-term value creation through platform companies. Its portfolio includes companies innovating in regenerative medicines, AI-driven drug toxicity prediction, and drug discovery simulation models. Dimension is positioned as a company builder and scientific partner, not just a capital allocator, aiming to catalyze the convergence of compute and biology at scale.